Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Parkinson disease”

Robotic Gait Rehabilitation in Parkinson's DiseaseTerminated
NCT05218187NAUpdated May 4, 2026
Sponsor: Indiana University
Parkinson Disease · Gait Disorder, Sensorimotor
United States
" Visual Characterization of Parkinson's Patients and Oculomotor or Perceptual Therapy"Completed
NCT06032130N/AUpdated May 4, 2026
Sponsor: University of Valencia
Parkinson Disease
Spain
tDCS on Parkinson's Disease CognitionRecruiting
NCT03025334NAUpdated May 1, 2026
Sponsor: University of Manitoba
Parkinson Disease · Mild Cognitive Impairment
Canada
A Trial to Evaluate Safety and Efficacy of a Product Named VGN-R08b in Parkinson's Disease Patients With GBA1 MutationsNot Yet Recruiting
NCT07414290Phase 1, Phase 2Updated May 1, 2026
Sponsor: Shanghai Vitalgen BioPharma Co., Ltd.
Parkinson Disease (PD)
China
Direct Measurement of Motor Cortical Responses to tDCSCompleted
NCT04759898N/AUpdated May 1, 2026
Sponsor: Medical University of South Carolina
Parkinson Disease
United States
Understanding Alpha-Synuclein Spread in Parkinson's Disease Through Blood Biomarkers and NeuroimagingNot Yet Recruiting
NCT07474779NAUpdated May 1, 2026
Sponsor: University of Pavia
Parkinson's Disease (PD) · GBA1 Parkinson Disease · REM Sleep Behavior Disorder (iRBD)
Italy
Evaluation of Neuroinflammation in Parkinson's Disease Using 18F-NOS PET/CTActive Not Recruiting
NCT04062526EARLY_Phase 1Updated May 1, 2026
Sponsor: University of Pennsylvania
Parkinson Disease · Healthy Volunteer
United States
Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)Active Not Recruiting
NCT03711032Phase 3Updated May 1, 2026
Sponsor: Merck Sharp & Dohme LLC
High-risk Non-muscle Invasive Bladder Cancer
United States, Australia, Austria, Belgium, Brazil +25 more
Acute Effects of AMPS on Cardiovascular, Functional Capacity and Postural Control in Patients With Parkinson's DiseaseCompleted
NCT05456282NAUpdated May 1, 2026
Sponsor: Universidad Católica del Maule
Parkinson Disease
Chile
Pain Assessment in Patients With Idiopathic Rapid Eye Movement (REM) Sleep Behaviour DisorderRecruiting
NCT07365566NAUpdated May 1, 2026
Sponsor: University Hospital, Toulouse
REM Sleep Behavior Disorder (iRBD) · Narcolepsy Type 1
France
Adaptive Deep Brain Stimulation to Improve Motor and Gait Functions in Parkinson's DiseaseActive Not Recruiting
NCT04675398NAUpdated May 1, 2026
Sponsor: Doris Wang, MD, PhD
Parkinson Disease
United States
Education for Adapted Physical Activity in Parkinson's DiseaseCompleted
NCT04340492NAUpdated Apr 30, 2026
Sponsor: University Hospital, Lille
Parkinson Disease
France
Using Low Intensity Focused Ultrasound to Modulate Deep Brain Areas for Tremor Control in Parkinson's Disease Patients.Completed
NCT06259708NAUpdated Apr 30, 2026
Sponsor: University of British Columbia
Parkinson Disease
Canada
Auditory Sleep Stimulation or Sham in People With Parkinson Disease Mild Cognitive Impairment During Cognitive TrainingRecruiting
NCT07441915NAUpdated Apr 30, 2026
Sponsor: University of Zurich
Parkinson's Disease · Mild Cognitive Impairment
Switzerland
Impact of Diet on the Microbiome-Immune-Brain Axis in Parkinson's DiseaseNot Yet Recruiting
NCT06463769NAUpdated Apr 29, 2026
Sponsor: University of Kiel
Parkinson Disease
Germany
Efficacy and Safety of Pembrolizumab (MK-3475) Plus Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus Enzalutamide Plus ADT in Participants With Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) (MK-3475-991/KEYNOTE-991)Completed
NCT04191096Phase 3Updated Apr 29, 2026
Sponsor: Merck Sharp & Dohme LLC
Metastatic Hormone-Sensitive Prostate Cancer
United States, Australia, Austria, Brazil, Canada +24 more
Effect of Kinesiotaping on Tremor in People With Parkinson's DiseaseCompleted
NCT07555847NAUpdated Apr 29, 2026
Sponsor: Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
PARKINSON DISEASE (Disorder) · Tremor · Tremor Associated With Tremor Dominant Parkinson's Disease
Turkey (Türkiye)
Studies of Brain and Body InteractionCompleted
NCT03672266N/AUpdated Apr 29, 2026
Sponsor: Rutgers University
Autistic Disorders Spectrum · Adhd · Asperger Syndrome · Alzheimer Disease
United States
Adaptive Deep Brain Stimulation for Freezing of Gait in Parkinson's DiseaseEnrolling By Invitation
NCT06819020NAUpdated Apr 29, 2026
Sponsor: Doris Wang, MD, PhD
Parkinson Disease
United States
World Data on Ambroxol for Patients With GD and GBA Related PDRecruiting
NCT04388969N/AUpdated Apr 29, 2026
Sponsor: Shaare Zedek Medical Center
Gaucher Disease · Parkinson Disease · GBA Gene Mutation
Israel
Mental Health Support for People Affected by Parkinson'sCompleted
NCT06992869NAUpdated Apr 29, 2026
Sponsor: University College, London
Parkinson's Disease (PD)
United Kingdom
The Effect of Long-term Daily Stimulation of the Brain With Pulsed Electromagnetic Fields on Parkinsons DiseaseRecruiting
NCT07306104NAUpdated Apr 29, 2026
Sponsor: University of Southern Denmark
PARKINSON DISEASE (Disorder)
Denmark
CuePD: Investigating the Effect of Personalised Auditory Cueing on Gait in Parkinson's DiseaseCompleted
NCT06941779NAUpdated Apr 29, 2026
Sponsor: Northumbria University
Parkinson's Disease (PD)
United Kingdom
Movement State-dependent Adaptive DBS for PDEnrolling By Invitation
NCT07424508NAUpdated Apr 29, 2026
Sponsor: Doris Wang, MD, PhD
Parkinson's Disease (PD)
United States
Effects of Exercise Training and Ketone Ester on Muscle Strength and Cardiovascular Response in Parkinson's DiseaseCompleted
NCT05948956NAUpdated Apr 28, 2026
Sponsor: University of Michigan
Parkinson Disease
United States

Previous page Next page